Health officials have asked if heart inflammation, which can occur with many types of infections, can be a rare side effect in teens and young adults after the second dose of the COVID-19 vaccine. I’m trying to judge.
An article about seven U.S. teenage boys in several states, published in pediatrics on Friday, is one of the latest reports of heart inflammation found after COVID-19 vaccination, but with the vaccine. No association has been proven.
Boys between the ages of 14 and 19 received Pfizer injections in April or May and developed chest pain within a few days. Imaging of the heart showed a type of myocardial inflammation called myocarditis.
There were no seriously ill patients. Dr. Preeti Jaggi, an infectious disease specialist at Emory University, who co-authored the report, is all healthy, able to return home after 2-6 days of hospitalization, and is “quite well”. It states.
She said heart changes are likely to be temporary, although further tracking is needed to determine how Seven was successful.
Only one of the seven boys in the pediatric report had evidence of previous COVID-19 infection, and doctors determined that no one had a rare coronavirus-related inflammatory condition. did.
These cases reflect reports from Israel about a young man diagnosed after being shot by Pfizer.
US Centers for Disease Control and Prevention Warned Doctors revealed last month that they were monitoring a few reports of heart inflammation in teens and young adults after the type of mRNA vaccination created by Pfizer and Moderna.
The CDC has not determined whether it is actually associated with an infectious disease and continues to encourage everyone over the age of 12 to be vaccinated against COVID-19. This is much more dangerous than a vaccine. Pfizer vaccines are available from age 12. Moderna Shot remains permitted for adult use only.
This type of heart inflammation can be caused by a variety of infections, including COVID-19 attacks and certain medications, and there are rare reports following other types of vaccination.
Authorities should investigate whether cases after COVID-19 vaccination occur more frequently than the expected “background rate”.
So far, the CDC states that most patients are male and report symptoms after the second dose, with symptoms improving rapidly.
“I think we’re in a waiting period where we need to determine if this is causal,” said John Grabenstein, a former director of the Pentagon’s vaccination program.
According to a pediatric editorial, there are more than 4 million cases of COVID-19 among children under the age of 18 in the United States, with more than 15,000 inpatients and at least 300 deaths.
He said the case of heart inflammation needed further investigation, but added that “the benefits of vaccination against this deadly and highly contagious disease far outweigh the potential risks.”
Dr. Yvonne Maldonado, co-author of the editor and chair of the American Academy of Pediatric Infectious Diseases Commission, is involved in Pfizer’s vaccine research, including research on the COVID-19 vaccine in children.
The Associated Press Faculty of Health Sciences support From the Science Education Department of Howard Hughes Medical Institute. AP is solely responsible for all content.
Copyright 2021 Associated Press. all rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Cardiac response is investigated as a possible rare vaccine for teens | Literature information | J-GLOBAL Science and Technology Link Center National
Source link Cardiac response is investigated as a possible rare vaccine for teens | Literature information | J-GLOBAL Science and Technology Link Center National